Adaptive Biotechnologies (ADPT) Accumulated Depreciation & Amortization (2018 - 2024)
Historic Accumulated Depreciation & Amortization for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q4 2024 value amounting to $87.8 million.
- Adaptive Biotechnologies' Accumulated Depreciation & Amortization rose 1991.29% to $87.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $87.8 million, marking a year-over-year increase of 1991.29%. This contributed to the annual value of $87.8 million for FY2024, which is 1991.29% up from last year.
- Per Adaptive Biotechnologies' latest filing, its Accumulated Depreciation & Amortization stood at $87.8 million for Q4 2024, which was up 1991.29% from $73.2 million recorded in Q4 2023.
- In the past 5 years, Adaptive Biotechnologies' Accumulated Depreciation & Amortization ranged from a high of $87.8 million in Q4 2024 and a low of $24.4 million during Q4 2020
- For the 5-year period, Adaptive Biotechnologies' Accumulated Depreciation & Amortization averaged around $55.2 million, with its median value being $54.4 million (2022).
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 5003.04% in 2022, then soared by 1991.29% in 2024.
- Adaptive Biotechnologies' Accumulated Depreciation & Amortization (Quarter) stood at $24.4 million in 2020, then soared by 48.58% to $36.2 million in 2021, then skyrocketed by 50.03% to $54.4 million in 2022, then skyrocketed by 34.75% to $73.2 million in 2023, then grew by 19.91% to $87.8 million in 2024.
- Its Accumulated Depreciation & Amortization was $87.8 million in Q4 2024, compared to $73.2 million in Q4 2023 and $54.4 million in Q4 2022.